NPC Creative Services
NPC Creative Services specializes in providing strategic public relations to healthcare, health IT, and technology software and service organizations, ranging from small- and mid-sized businesses to Fortune 500 corporations and professional trade associations.
Whether the need is for an agency to provide comprehensive public relations services or to support an in-house team, NPC has the industry expertise and connections necessary to get the job done right, on time and within budget.
Few agencies can match the level of expertise, industry understanding and personalized service NPC brings to its client relationships.
-
Emergence of Caring Algorithms
Trust is critical in healthcare, not only trust between patients and providers but also trust in the health information used to make clinical decisions. Health information must be accurate, reliable, and complete. Unfortunately, data is inherently dirty. AHIMA estimates that 5-10% of patient records are duplicates, and some hospitals report duplicate rates as high as 22%. Meanwhile, one study found that 50% of patient notes are duplicated.
Even the most advanced AI-enabled automation technologies can’t fully resolve incorrect or incomplete duplicate patient records and other integrity issues. Matching algorithms can reduce human error, enhance care quality, and minimize the risk of misidentification, misdiagnoses, and improper or duplicative treatment. However, today’s EHRs lack sufficiently advanced matching algorithms, as their effectiveness depends on the underlying technology platform.
Health IT Answers» -
The Perfect Storm: Surging Audits, Clawbacks, and the Future of Healthcare Revenue Integrity
Healthcare finance executives face an intensifying storm of audits, denials, and clawbacks that threaten their organization’s financial stability. Couple that with an environment of heightened regulatory and payer scrutiny, and it becomes clear that proactive risk monitoring and AI-driven compliance strategies are no longer optional—they are imperative.
Health IT Answers» -
NeuroEM Therapeutics Closes Initial Rounds in $5 Million Equity Raise to Commercialize Drug-free Alzheimer’s Treatment
NeuroEM Therapeutics, an award-winning clinical-stage biotechnology research company pioneering the use of radio frequencies to reverse Alzheimer’s disease, has closed initial rounds totaling $1.33 million of a $5 million equity raise with BlueLake.vc.
The Series A round supports continued progress toward commercialization of NeuroEM’s Transcranial Electromagnetic Treatment (TEMT-RF) to prevent and treat cognitive decline caused by aging or Alzheimer’s and other neurodegenerative diseases.
Electronic Health Reporter»